Alp SuleimanGrowth Partner

Patent Portfolio Management

Patent count is not a success metric, it is a cost line. A portfolio becomes an asset only when it is tied to your product plan, your negotiating power and your revenue.

EnterpriseStrategy 74 / 885 min read

Author: Published

In many companies the patent portfolio lives like an archive of the legal department. Annual renewal fees are paid automatically, new filings arrive according to engineers' enthusiasm, and nobody can say which patent protects which product, which rival or which revenue.

Patent management looks like a legal job, but it is really a capital allocation problem. Every patent has a filing cost, a protection cost and a renewal cost; in return you expect either freedom to operate, bargaining power or revenue. If that equation has not been built, what you hold is not a portfolio but a pile.

When you need it

If your technology is the distinguishing feature of your product and easy to copy (hardware, pharma, materials, semiconductors, certain algorithmic methods), patent strategy should come early. If you work in the same field as large rivals and face the risk of patent litigation, a defensive portfolio is the card that will speak for you at a future settlement table.

Other signals: your technology has value that others could license, you have inventions that could become part of a standard (wireless communication, video coding), or investors and acquirers have started asking for your IP inventory.

It can also be too early. If your product is still changing fast, what you protect today may be a design you no longer use in six months. And in some areas a trade secret protects better than a patent: filing discloses the invention to the public. The formula of Coca-Cola, protected as a secret rather than a patent, is the frequently cited example. Deciding which invention suits a patent and which suits secrecy is the first step of strategy.

What most teams miss

Patent count can be a source of pride, but it is not a strategy. That IBM has for many years been among the companies receiving the most US patents, or that licensing revenue is a major part of Qualcomm's business model, comes less from the numbers than from these companies tying their portfolios to a purpose. At Qualcomm, patents linked to wireless standards are licensed like a product. That is not what randomly accumulated patents deliver.

A portfolio has three distinct functions and each calls for different evaluation: defense (freedom to operate and counter-suit strength), revenue (licensing) and position (a signal of technological leadership to investors, partners and rivals). Most companies mix the three and accumulate patents without saying which one they aim for. A portfolio with no declared purpose produces nothing but annual renewal fees.

The second gap is seeing that patent protection alone is not a wall. A patent is only as strong as the litigation budget you will spend to defend it. A small company often cannot sustain a patent suit against a large rival. So know up front whether a patent is for you a “business” (license negotiation) or a “deterrent” (threat of counter-attack).

The third is that deliberate openness is also a strategy. Tesla's 2014 announcement that it would not pursue claims against good-faith users of its electric vehicle patents was a decision to invest in growing its own market. Not for every technology; but while the market itself is small, closing the door with patents can shrink your own growth space.

Every patent you hold should have a job. If you cannot name the job, you should not pay the renewal bill either.

The playbook

1. Match the portfolio inventory to a product and rival map

Tag every patent (or patent family) with three questions: which product or service does it protect? Against which rival does it have value? Is it licensable? Write the answers in three columns. Patents tied to none of them are pruning candidates.

2. Split the portfolio into tiers

“Crown jewels” (those concerning the core product and the most important rival), “supporting” (those needed for a product family or a standard) and “to prune” (unused, nearing expiry, outside the product plan). Allocate budget in that order: the fullest protection for crown jewels, no renewal for the prune tier.

3. Tie new invention decisions to the product roadmap

Review invention disclosures from engineers in a committee: is it in the product roadmap, is a rival working in the same area, patent or trade secret? Decision criteria should be written; otherwise filings are shaped by personal enthusiasm. Encourage engineers, but tie the incentive not to “number of filings” but to “valuable patents entering the portfolio.”

4. Run freedom-to-operate analysis

Before entering a new product or market, check whether others' patents block you (freedom to operate). The analysis looks expensive, but the cost of an infringement notice that arrives after a product launch is far higher.

5. Operate the licensing and cross-licensing arm

Start a systematic search to license patents you do not use but that have value. Build a ready portfolio argument for cross-license negotiation against a possible dispute with rivals. Licensing can be a revenue line, but it needs a dedicated team, targets and process.

What to measure

  • Share of patents tied to a product: What proportion of the portfolio maps to a live product or strategic purpose? If low, the portfolio is heavy and ownerless.
  • Cost per patent versus value obtained: Renewal and protection cost relative to license income, deterrence or cross-license value.
  • License revenue (if any) and license negotiation outcomes: A lagging indicator; shows the portfolio's bargaining power.
  • Share of products covered by freedom-to-operate analysis: How many new launches go out with patent risk assessed beforehand? A leading risk indicator.

Pitfalls

Count obsession. Reporting patent count as success encourages low-quality filings and unnecessary renewal cost. Report the value tied to patents, not the number.

The cost of disclosure. A patent filing makes the invention public. For a narrow patent a rival can easily design around, disclosing valuable information can be a loss.

A right you cannot enforce. If you lack the power to litigate, your patent stays on paper. Account for budget and legal capacity from the start.

Start this week

  1. Ask legal or the IP team for the patent inventory and add product, rival and license value columns next to each patent.
  2. List the patents with renewal costs coming in the next twelve months; flag those not tied to the product plan as pruning candidates.
  3. Set up a monthly decision meeting of engineering, product and legal to review new invention disclosures.

Put it to work

Let’s adapt this strategy to your company.

Let’s pin down which stage you’re in and whether this is the right lever for you right now.

↑ All strategies